首页 > 最新文献

Human reproduction最新文献

英文 中文
Mendelian randomization and multi-omics approach analyses reveal impaired glucose metabolism and oxidative phosphorylation in visceral adipose tissue of women with polycystic ovary syndrome 孟德尔随机化和多组学方法分析揭示了多囊卵巢综合征妇女内脏脂肪组织中葡萄糖代谢和氧化磷酸化受损的情况
IF 6.1 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-25 DOI: 10.1093/humrep/deae244
Yurong Zhang, Xintong Jiang, Xueling Song, Jiajia Zhang, Weian Mao, Wei Chen, Shuai Yuan, Yijie Chen, Liangshan Mu, Yue Zhao
STUDY QUESTION What is the significance of visceral adipose tissue (VAT) in the pathogenesis of polycystic ovary syndrome (PCOS) and its impact on the regulation of metabolic disorders in women with PCOS? SUMMARY ANSWER We revealed a potentially causal relationship between increased genetically predicted VAT and PCOS-related traits, and found that VAT exhibited impaired glucose metabolism and mitochondrial oxidative phosphorylation (OXPHOS) in women with PCOS. WHAT IS KNOWN ALREADY PCOS is a common reproductive endocrine disorder accompanied by many metabolic abnormalities. Adipose tissue is a metabolically active endocrine organ that regulates multiple physiological processes, and VAT has a much stronger association with metabolism than subcutaneous adipose tissue does. STUDY DESIGN, SIZE, DURATION Mendelian randomization (MR) analysis was used to investigate the potential causal association between genetically predicted VAT and the risk of PCOS. Data for MR analysis were extracted from European population cohorts. VAT samples from sixteen PCOS patients and eight control women who underwent laparoscopic surgery were collected for proteomics and targeted metabolomics analyses. PARTICIPANTS/MATERIALS, SETTING, METHODS PCOS was diagnosed according to the 2003 Rotterdam Criteria. The control subjects were women who underwent laparoscopic investigation for infertility or benign indications. Proteomics was performed by TMT labeling and liquid chromatography-tandem mass spectrometry analysis, and targeted metabolomics was performed by ultra-performance liquid chromatography-tandem mass spectrometry analysis. The key differentially expressed proteins (DEPs) were validated by immunoblotting. MAIN RESULTS AND THE ROLE OF CHANCE MR analysis revealed a potentially causal relationship between increased genetically predicted VAT and PCOS, as well as related traits, such as polycystic ovaries, total testosterone, bioavailable testosterone, and anti-Müllerian hormone, while a negative relationship was found with sex hormone-binding globulin. Enrichment pathway analysis of DEPs indicated the inhibition of glycolysis and activation of mitochondrial OXPHOS in the VAT of PCOS patients. MR analysis revealed that key DEPs involved in glycolysis and OXPHOS were significantly linked to PCOS and its related traits. Dot blot assay confirmed a significant decrease in glycolysis enzymes PKM2 and HK1, and an increase in mitochondrial Complex I and III subunits, NDUFS3 and UQCR10. Moreover, metabolomics analysis confirmed down-regulated metabolites of energy metabolic pathways, in particular glycolysis. Further analysis of PCOS and control subjects of normal weight revealed that dysregulation of glucose metabolism and OXPHOS in VAT of women with PCOS was independent of obesity. LARGE SCALE DATA The mass spectrometry proteomics data have been deposited to the iProX database (http://www.iprox.org) with the iProX accession: IPX0005774001. LIMITATIONS, REASONS FOR CAUTION There
研究问题 内脏脂肪组织(VAT)在多囊卵巢综合征(PCOS)发病机制中的意义及其对多囊卵巢综合征女性代谢紊乱调节的影响是什么?简答 我们揭示了基因预测的腹腔脂肪组织增加与多囊卵巢综合症相关特征之间的潜在因果关系,并发现多囊卵巢综合症女性患者的腹腔脂肪组织表现出葡萄糖代谢和线粒体氧化磷酸化(OXPHOS)受损。已有知识 多囊卵巢综合症是一种常见的生殖内分泌疾病,伴有多种代谢异常。脂肪组织是一种代谢活跃的内分泌器官,调节多种生理过程,与皮下脂肪组织相比,脂肪增值与代谢的关系更为密切。研究设计、规模、持续时间 采用孟德尔随机化(MR)分析法研究遗传预测的 VAT 与 PCOS 风险之间的潜在因果关系。用于 MR 分析的数据来自欧洲人群队列。收集了 16 名接受腹腔镜手术的多囊卵巢综合症患者和 8 名对照组女性的 VAT 样本,用于蛋白质组学和靶向代谢组学分析。根据 2003 年鹿特丹标准诊断多囊卵巢综合症。对照组受试者为因不孕或良性适应症接受腹腔镜检查的女性。蛋白质组学采用 TMT 标记和液相色谱-串联质谱分析法,靶向代谢组学采用超高效液相色谱-串联质谱分析法。关键的差异表达蛋白(DEPs)通过免疫印迹进行了验证。主要结果和偶然性的作用 MR 分析表明,基因预测的增值税增加与多囊卵巢综合症以及多囊卵巢、总睾酮、生物可用睾酮和抗缪勒氏管激素等相关性状之间可能存在因果关系,而与性激素结合球蛋白之间则存在负相关关系。DEPs的富集通路分析表明,多囊卵巢综合症患者的血管内皮生长因子抑制了糖酵解,激活了线粒体OXPHOS。磁共振分析显示,参与糖酵解和OXPHOS的关键DEPs与多囊卵巢综合征及其相关特征有显著联系。点印迹分析证实,糖酵解酶 PKM2 和 HK1 明显减少,线粒体复合体 I 和 III 亚基、NDUFS3 和 UQCR10 增加。此外,代谢组学分析证实了能量代谢途径代谢物的下调,尤其是糖酵解。对多囊卵巢综合症患者和体重正常的对照受试者的进一步分析表明,多囊卵巢综合症女性血管内皮细胞葡萄糖代谢和氧分解代谢失调与肥胖无关。大规模数据 质谱蛋白质组学数据已存入 iProX 数据库 (http://www.iprox.org),iProX 编号为 IPX0005774001:IPX0005774001。局限性、注意事项 某些暴露数据和结果数据可能存在重叠,这可能会影响磁共振分析的结果。研究结果的广泛意义 关键酶蛋白表达的变化会影响其活性并破坏增值税的能量代谢平衡,这为确定 PCOS 的潜在干预目标提供了有价值的见解。研究经费/合作利益 本研究得到了国家重点研发计划项目(2021YFC2700402)、国家自然科学基金(82071608、82271665)、北京大学第三医院临床重点项目(BYSY2022043)和CAMS医学科学创新基金(2019-I2M-5-001)的支持。所有作者均未报告利益冲突。试验注册号 n/a。
{"title":"Mendelian randomization and multi-omics approach analyses reveal impaired glucose metabolism and oxidative phosphorylation in visceral adipose tissue of women with polycystic ovary syndrome","authors":"Yurong Zhang, Xintong Jiang, Xueling Song, Jiajia Zhang, Weian Mao, Wei Chen, Shuai Yuan, Yijie Chen, Liangshan Mu, Yue Zhao","doi":"10.1093/humrep/deae244","DOIUrl":"https://doi.org/10.1093/humrep/deae244","url":null,"abstract":"STUDY QUESTION What is the significance of visceral adipose tissue (VAT) in the pathogenesis of polycystic ovary syndrome (PCOS) and its impact on the regulation of metabolic disorders in women with PCOS? SUMMARY ANSWER We revealed a potentially causal relationship between increased genetically predicted VAT and PCOS-related traits, and found that VAT exhibited impaired glucose metabolism and mitochondrial oxidative phosphorylation (OXPHOS) in women with PCOS. WHAT IS KNOWN ALREADY PCOS is a common reproductive endocrine disorder accompanied by many metabolic abnormalities. Adipose tissue is a metabolically active endocrine organ that regulates multiple physiological processes, and VAT has a much stronger association with metabolism than subcutaneous adipose tissue does. STUDY DESIGN, SIZE, DURATION Mendelian randomization (MR) analysis was used to investigate the potential causal association between genetically predicted VAT and the risk of PCOS. Data for MR analysis were extracted from European population cohorts. VAT samples from sixteen PCOS patients and eight control women who underwent laparoscopic surgery were collected for proteomics and targeted metabolomics analyses. PARTICIPANTS/MATERIALS, SETTING, METHODS PCOS was diagnosed according to the 2003 Rotterdam Criteria. The control subjects were women who underwent laparoscopic investigation for infertility or benign indications. Proteomics was performed by TMT labeling and liquid chromatography-tandem mass spectrometry analysis, and targeted metabolomics was performed by ultra-performance liquid chromatography-tandem mass spectrometry analysis. The key differentially expressed proteins (DEPs) were validated by immunoblotting. MAIN RESULTS AND THE ROLE OF CHANCE MR analysis revealed a potentially causal relationship between increased genetically predicted VAT and PCOS, as well as related traits, such as polycystic ovaries, total testosterone, bioavailable testosterone, and anti-Müllerian hormone, while a negative relationship was found with sex hormone-binding globulin. Enrichment pathway analysis of DEPs indicated the inhibition of glycolysis and activation of mitochondrial OXPHOS in the VAT of PCOS patients. MR analysis revealed that key DEPs involved in glycolysis and OXPHOS were significantly linked to PCOS and its related traits. Dot blot assay confirmed a significant decrease in glycolysis enzymes PKM2 and HK1, and an increase in mitochondrial Complex I and III subunits, NDUFS3 and UQCR10. Moreover, metabolomics analysis confirmed down-regulated metabolites of energy metabolic pathways, in particular glycolysis. Further analysis of PCOS and control subjects of normal weight revealed that dysregulation of glucose metabolism and OXPHOS in VAT of women with PCOS was independent of obesity. LARGE SCALE DATA The mass spectrometry proteomics data have been deposited to the iProX database (http://www.iprox.org) with the iProX accession: IPX0005774001. LIMITATIONS, REASONS FOR CAUTION There ","PeriodicalId":13003,"journal":{"name":"Human reproduction","volume":"147 1","pages":""},"PeriodicalIF":6.1,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142490622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epigenetic aging and fecundability: the Norwegian Mother, Father and Child Cohort Study 表观遗传衰老与生育能力:挪威母亲、父亲和子女队列研究
IF 6.1 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-25 DOI: 10.1093/humrep/deae242
Lise Andrea Arge, Yunsung Lee, Karoline Hansen Skåra, Mikko Myrskylä, Cecilia Høst Ramlau-Hansen, Siri Eldevik Håberg, Maria Christine Magnus
STUDY QUESTION Is there an association between male or female epigenetic age acceleration (EAA) or deceleration (EAD) and fecundability? SUMMARY ANSWER We do not find compelling evidence of an association between EAA or EAD and fecundability. WHAT IS KNOWN ALREADY Prior research has shown that female accelerated epigenetic aging is associated with unfavorable clinical fecundity outcomes and use of in vitro fertilization, and that epigenetic aging in sperm cells is associated with unfavorable sperm parameters. Studies of epigenetic aging and fecundability among individuals who conceive naturally are lacking. STUDY DESIGN, SIZE, DURATION This study is based on the Norwegian Mother, Father and Child Cohort Study (MoBa), a population-based pregnancy cohort which recruited pregnant couples between 1999 and 2008. We used data from 1657 couples (women and men) with planned naturally conceived pregnancies and available blood samples. PARTICIPANTS/MATERIALS, SETTING, METHODS Methylation levels were measured in DNA from blood samples taken recruitment (at ∼18 gestational weeks) from pregnant women and their partners using the Illumina Methylation EPIC Array. To obtain a measure of EAA/EAD, we performed a linear regression of each of seven different established epigenetic biomarkers (DNAmAge by Horvath, DNAmAge by Hannum et al., PhenoAge by Levine et al., DunedinPoAm by Belsky et al., DunedinPACE by Belsky et al., DNAmTL by Lu et al., and GrimAge by Lu et al.) against chronological age. We fitted proportional probability regression models to obtain fecundability ratios (FRs) for each standard deviation increase in epigenetic aging, and obtained crude and adjusted (for body mass index, smoking, and education level) estimates. Results were evaluated at a false discovery rate (FDR) of 5%. We evaluated all models for non-linear associations using categories of epigenetic age where appropriate. MAIN RESULTS AND THE ROLE OF CHANCE Although the DunedinPACE clock in males demonstrated slightly increasing fecundability with increasing EAA (adjusted FR 1.05 per one standard deviation increase in EAA, 95% CI 1.00–1.10), this was not robust when evaluated at an FDR of 5%. We found evidence of non-linearity between biological aging and fecundability in two models in females and three models in males, but non-linear associations were weak and conflicting. LIMITATIONS, REASONS FOR CAUTION As MoBa is a pregnancy cohort, our findings may not be generalizable to all couples attempting conception. Fecundability is a couple-level measure, and any impacts of epigenetic aging in each partner may be obscured by effects of the other partner. WIDER IMPLICATIONS OF THE FINDINGS Our findings contrast with those of prior studies, which have indicated an association between EAA and unfavorable clinical fertility outcomes in populations using fertility treatments, possibly due to less important effects of epigenetic aging among couples who conceive naturally. More research is needed on
研究问题 男性或女性表观遗传年龄加速(EAA)或减速(EAD)与受精能力之间是否存在关联?简答 我们没有发现令人信服的证据表明 EAA 或 EAD 与受精能力有关。既往研究表明,女性表观遗传加速衰老与不利的临床受孕结果和体外受精的使用有关,精子细胞的表观遗传衰老与不利的精子参数有关。目前还缺乏对自然受孕者的表观遗传老化和受精能力的研究。研究设计、规模和持续时间 本研究基于挪威母亲、父亲和儿童队列研究(MoBa),这是一项基于人口的怀孕队列研究,在1999年至2008年间招募了怀孕夫妇。我们使用了 1657 对计划自然怀孕的夫妇(女性和男性)的数据,并采集了他们的血液样本。使用 Illumina Methylation EPIC Array 测量了孕妇及其伴侣在妊娠 18 周时采集的血液样本中 DNA 的甲基化水平。为了获得 EAA/EAD 的测量值,我们将 7 种不同的既定表观遗传生物标志物(Horvath 的 DNAmAge、Hannum 等人的 DNAmAge、Levine 等人的 PhenoAge、Belsky 等人的 DunedinPoAm、Belsky 等人的 DunedinPACE、Lu 等人的 DNAmTL 和 Lu 等人的 GrimAge)中的每一种与实际年龄进行了线性回归。我们拟合了比例概率回归模型,以获得表观遗传老化每增加一个标准差的受精率比值(FRs),并获得粗略估计值和调整估计值(根据体重指数、吸烟和教育水平)。我们以 5%的错误发现率 (FDR) 对结果进行了评估。我们酌情使用表观遗传年龄分类对所有非线性关联模型进行了评估。主要结果和偶然性的作用 虽然 DunedinPACE 时钟显示男性的受精率随着 EAA 的增加而略有增加(EAA 每增加一个标准差,调整 FR 值为 1.05,95% CI 为 1.00-1.10),但在 FDR 为 5%的情况下进行评估时,这一结果并不稳健。我们在两个雌性模型和三个雄性模型中发现了生物衰老与受精率之间非线性关系的证据,但非线性关系较弱且相互矛盾。局限性、注意事项 由于 MoBa 是一个怀孕队列,我们的研究结果可能无法推广到所有试图受孕的夫妇。可育性是一种夫妇层面的衡量标准,每对夫妇表观遗传老化的任何影响都可能被另一对夫妇的影响所掩盖。我们的研究结果与之前的研究结果形成了鲜明的对比,之前的研究结果表明,在使用生育治疗的人群中,EAA 与不利的临床生育结果之间存在关联,这可能是由于在自然受孕的夫妇中,表观遗传老化的影响并不那么重要。我们需要对基于血液的 EAA 与男女临床生育参数之间的关系进行更多的研究。研究经费/合作利益 本研究得到了挪威研究委员会(Research Council of Norway)的支持,包括医学生研究计划资助项目(项目编号:271555/F20)、卓越中心资助项目(项目编号:262700)以及妇女健康计划资助项目(320656)。此外,该研究还获得了战略研究委员会(SRC)、FLUX联合会(决定号:345130和345131)、美国国家老龄化研究所(R01AG075208)、马克斯-普朗克协会(决定号:5714240218)、赫尔辛基大学社会科学学院简和阿托斯-埃尔科基金会(Jane and Aatos Erkko Foundation)以及赫尔辛基市、万塔市和埃斯波市对马克斯-普朗克-赫尔辛基大学中心的资助,以及欧洲研究理事会的共同资助;欧洲研究理事会(ERC Synergy、BIOSFER,资助号 101071773;地平线 2020 研究与创新计划,资助号 947684)。作者声明无利益冲突。试验注册号 n/a。
{"title":"Epigenetic aging and fecundability: the Norwegian Mother, Father and Child Cohort Study","authors":"Lise Andrea Arge, Yunsung Lee, Karoline Hansen Skåra, Mikko Myrskylä, Cecilia Høst Ramlau-Hansen, Siri Eldevik Håberg, Maria Christine Magnus","doi":"10.1093/humrep/deae242","DOIUrl":"https://doi.org/10.1093/humrep/deae242","url":null,"abstract":"STUDY QUESTION Is there an association between male or female epigenetic age acceleration (EAA) or deceleration (EAD) and fecundability? SUMMARY ANSWER We do not find compelling evidence of an association between EAA or EAD and fecundability. WHAT IS KNOWN ALREADY Prior research has shown that female accelerated epigenetic aging is associated with unfavorable clinical fecundity outcomes and use of in vitro fertilization, and that epigenetic aging in sperm cells is associated with unfavorable sperm parameters. Studies of epigenetic aging and fecundability among individuals who conceive naturally are lacking. STUDY DESIGN, SIZE, DURATION This study is based on the Norwegian Mother, Father and Child Cohort Study (MoBa), a population-based pregnancy cohort which recruited pregnant couples between 1999 and 2008. We used data from 1657 couples (women and men) with planned naturally conceived pregnancies and available blood samples. PARTICIPANTS/MATERIALS, SETTING, METHODS Methylation levels were measured in DNA from blood samples taken recruitment (at ∼18 gestational weeks) from pregnant women and their partners using the Illumina Methylation EPIC Array. To obtain a measure of EAA/EAD, we performed a linear regression of each of seven different established epigenetic biomarkers (DNAmAge by Horvath, DNAmAge by Hannum et al., PhenoAge by Levine et al., DunedinPoAm by Belsky et al., DunedinPACE by Belsky et al., DNAmTL by Lu et al., and GrimAge by Lu et al.) against chronological age. We fitted proportional probability regression models to obtain fecundability ratios (FRs) for each standard deviation increase in epigenetic aging, and obtained crude and adjusted (for body mass index, smoking, and education level) estimates. Results were evaluated at a false discovery rate (FDR) of 5%. We evaluated all models for non-linear associations using categories of epigenetic age where appropriate. MAIN RESULTS AND THE ROLE OF CHANCE Although the DunedinPACE clock in males demonstrated slightly increasing fecundability with increasing EAA (adjusted FR 1.05 per one standard deviation increase in EAA, 95% CI 1.00–1.10), this was not robust when evaluated at an FDR of 5%. We found evidence of non-linearity between biological aging and fecundability in two models in females and three models in males, but non-linear associations were weak and conflicting. LIMITATIONS, REASONS FOR CAUTION As MoBa is a pregnancy cohort, our findings may not be generalizable to all couples attempting conception. Fecundability is a couple-level measure, and any impacts of epigenetic aging in each partner may be obscured by effects of the other partner. WIDER IMPLICATIONS OF THE FINDINGS Our findings contrast with those of prior studies, which have indicated an association between EAA and unfavorable clinical fertility outcomes in populations using fertility treatments, possibly due to less important effects of epigenetic aging among couples who conceive naturally. More research is needed on ","PeriodicalId":13003,"journal":{"name":"Human reproduction","volume":"125 1","pages":""},"PeriodicalIF":6.1,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142489367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multi-omics PGT: re-evaluation of euploid blastocysts for implantation potential based on RNA sequencing 多组学 PGT:基于 RNA 测序重新评估优倍体囊胚的植入潜力
IF 6.1 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-16 DOI: 10.1093/humrep/deae237
Jiamin Jin, Jieliang Ma, Xiufen Wang, Fang Hong, YinLi Zhang, Feng Zhou, Cheng Wan, Yangyun Zou, Ji Yang, Sijia Lu, Xiaomei Tong
STUDY QUESTION In addition to chromosomal euploidy, can the transcriptome of blastocysts be used as a novel predictor of embryo implantation potential? SUMMARY ANSWER This retrospective analysis showed that based on differentially expressed genes (DEGs) between euploid blastocysts which resulted and did not result in a clinical pregnancy, machine learning models could help improve implantation rates by blastocyst optimization. WHAT IS KNOWN ALREADY Embryo implantation is a multifaceted process, with implantation loss and pregnancy failure related not only to blastocyst euploidy but also to the intricate dialog between blastocyst and endometrium. Although in vitro studies have revealed the characteristics of trophectoderm (TE) differentiation in implanted blastocysts and the function of TE placentation at the implantation site, the precise molecular mechanisms of embryo implantation and their clinical application remain to be fully elucidated. STUDY DESIGN, SIZE, DURATION This study involved 102 patients who underwent 111 cycles for preimplantation genetic testing for aneuploidies (PGT-A) between March 2022 and July 2023. PARTICIPANTS/MATERIALS, SETTING, METHODS The study included 412 blastocysts biopsied at Day 5 [D5] or Day 6 [D6] for patients who underwent PGT-A. The biopsy lysates were split and subjected to DNA and RNA sequencing (DNA- and RNA-seq). One part was used for PGT-A to detect DNA copy number variations, whereas the other part was assessed simultaneously by RNA-seq to determine the transcriptome characteristics. To validate the reliability and accuracy of RNA-seq obtained from this strategy, we initially analyzed the transcriptome of blastocysts with chromosomal aneuploidies. Subsequently, we compared the transcriptomic features of blastocysts with different rates of formation (D5 vs D6) and investigated the network of interactions between key blastulation genes and the receptive endometrium. Then to evaluate the implantation potential of euploid blastocysts, we identified DEGs between euploid blastocysts that resulted in clinical pregnancy (defined as the presence of a gestational sac detected by ultrasound after 5 weeks) and those that did not. These DEGs were then employed to construct a predictive model for optimizing blastocyst selection. MAIN RESULTS AND THE ROLE OF CHANCE The successful detection rate of PGT-A was remarkably high at 99.8%. The RNA data may infer aneuploidy for both trisomy and monosomy. Between the euploid blastocysts that formed on D5 and D6, 187 DEGs were predominantly involved in cell differentiation for embryonic placenta development, the PPAR signaling pathway, and the Notch signaling pathway. These D5/D6 DEGs also exhibited a functional dialog with the receptive phase endometrium-specific genes through protein–protein interaction networks, indicating that the embryo undergoes further differentiation for post-implantation development. Furthermore, a modeling strategy using 280 DEGs between blastocysts le
研究问题 除了染色体整倍体外,囊胚的转录组能否用作胚胎植入潜力的新预测指标?简要解答 这项回顾性分析表明,基于导致临床妊娠和未导致临床妊娠的优倍体囊胚之间的差异表达基因 (DEG),机器学习模型可通过优化囊胚来帮助提高植入率。已知信息 胚胎植入是一个多方面的过程,植入损失和妊娠失败不仅与囊胚的非整倍体有关,还与囊胚和子宫内膜之间错综复杂的对话有关。虽然体外研究已经揭示了植入囊胚的滋养外胚层(TE)分化特征和植入部位滋养外胚层胎盘的功能,但胚胎植入的确切分子机制及其临床应用仍有待全面阐明。研究设计、规模、持续时间 本研究涉及 102 例患者,他们在 2022 年 3 月至 2023 年 7 月期间接受了 111 个周期的非整倍体植入前基因检测(PGT-A)。参与者/材料、设置、方法 该研究包括接受 PGT-A 的患者在第 5 天[D5]或第 6 天[D6]活检的 412 个囊胚。活检裂解物被分割并进行 DNA 和 RNA 测序(DNA 和 RNA-seq)。其中一部分用于 PGT-A,以检测 DNA 拷贝数变异,另一部分则同时进行 RNA-seq 评估,以确定转录组特征。为了验证这种策略获得的 RNA-seq 的可靠性和准确性,我们首先分析了染色体非整倍体囊胚的转录组。随后,我们比较了不同形成率(D5 与 D6)的囊胚的转录组特征,并研究了关键囊胚形成基因与受体子宫内膜之间的相互作用网络。然后,为了评估优倍囊胚的植入潜能,我们鉴定了导致临床妊娠(定义为 5 周后超声检测到孕囊的存在)的优倍囊胚与未导致临床妊娠的优倍囊胚之间的 DEGs。然后利用这些 DEGs 构建了优化囊胚选择的预测模型。主要结果和偶然性的作用 PGT-A 的成功检测率高达 99.8%。RNA 数据可推断出三体和单体的非整倍体。在 D5 和 D6 形成的非整倍体囊胚中,187 个 DEGs 主要涉及胚胎胎盘发育的细胞分化、PPAR 信号通路和 Notch 信号通路。这些D5/D6 DEGs还通过蛋白-蛋白相互作用网络与受孕期子宫内膜特异性基因进行功能性对话,表明胚胎在着床后的发育过程中会进一步分化。此外,还采用了一种建模策略,利用导致成功临床妊娠或未能产生临床妊娠的囊胚之间的 280 个 DEGs 来完善优倍体胚胎优化,随机森林(RF)、支持向量机和线性判别分析模型的曲线下面积分别达到了 0.88、0.71 和 0.84。最后,使用 RF 模型对 83 个移植的优倍囊胚进行了回顾性分析,确定了三种类型的优倍胚胎,其植入潜力呈下降趋势。值得注意的是,良好组的植入率明显高于中等组(88.6% vs 50.0% P = 0.001),中等组的植入率高于不良组(50.0% vs 20.8%,P = 0.035)。局限性、注意事项 由于样本量不足,因此需要进行前瞻性研究来验证上述模型的临床有效性。由于我们没有对只导致生化妊娠但临床妊娠失败的囊胚进行单独分析,我们的分类系统仍需进行修改以筛选这些胚胎。研究结果的广泛意义 囊胚转录组分析为预测胚胎植入潜力提供了一种新方法,可用于优化临床胚胎选择。该排序系统可有效减少临床妊娠所需的时间和成本。研究经费/利益冲突 本研究得到了浙江省 "先导专项 "和 "领雁计划"(编号:2023C03034)、国家自然科学基金(82101709)和国家重点研发计划青年科学家项目(编号:2022YFC2702300)的资助。作者声明不存在利益冲突。试验注册号 n/a。
{"title":"Multi-omics PGT: re-evaluation of euploid blastocysts for implantation potential based on RNA sequencing","authors":"Jiamin Jin, Jieliang Ma, Xiufen Wang, Fang Hong, YinLi Zhang, Feng Zhou, Cheng Wan, Yangyun Zou, Ji Yang, Sijia Lu, Xiaomei Tong","doi":"10.1093/humrep/deae237","DOIUrl":"https://doi.org/10.1093/humrep/deae237","url":null,"abstract":"STUDY QUESTION In addition to chromosomal euploidy, can the transcriptome of blastocysts be used as a novel predictor of embryo implantation potential? SUMMARY ANSWER This retrospective analysis showed that based on differentially expressed genes (DEGs) between euploid blastocysts which resulted and did not result in a clinical pregnancy, machine learning models could help improve implantation rates by blastocyst optimization. WHAT IS KNOWN ALREADY Embryo implantation is a multifaceted process, with implantation loss and pregnancy failure related not only to blastocyst euploidy but also to the intricate dialog between blastocyst and endometrium. Although in vitro studies have revealed the characteristics of trophectoderm (TE) differentiation in implanted blastocysts and the function of TE placentation at the implantation site, the precise molecular mechanisms of embryo implantation and their clinical application remain to be fully elucidated. STUDY DESIGN, SIZE, DURATION This study involved 102 patients who underwent 111 cycles for preimplantation genetic testing for aneuploidies (PGT-A) between March 2022 and July 2023. PARTICIPANTS/MATERIALS, SETTING, METHODS The study included 412 blastocysts biopsied at Day 5 [D5] or Day 6 [D6] for patients who underwent PGT-A. The biopsy lysates were split and subjected to DNA and RNA sequencing (DNA- and RNA-seq). One part was used for PGT-A to detect DNA copy number variations, whereas the other part was assessed simultaneously by RNA-seq to determine the transcriptome characteristics. To validate the reliability and accuracy of RNA-seq obtained from this strategy, we initially analyzed the transcriptome of blastocysts with chromosomal aneuploidies. Subsequently, we compared the transcriptomic features of blastocysts with different rates of formation (D5 vs D6) and investigated the network of interactions between key blastulation genes and the receptive endometrium. Then to evaluate the implantation potential of euploid blastocysts, we identified DEGs between euploid blastocysts that resulted in clinical pregnancy (defined as the presence of a gestational sac detected by ultrasound after 5 weeks) and those that did not. These DEGs were then employed to construct a predictive model for optimizing blastocyst selection. MAIN RESULTS AND THE ROLE OF CHANCE The successful detection rate of PGT-A was remarkably high at 99.8%. The RNA data may infer aneuploidy for both trisomy and monosomy. Between the euploid blastocysts that formed on D5 and D6, 187 DEGs were predominantly involved in cell differentiation for embryonic placenta development, the PPAR signaling pathway, and the Notch signaling pathway. These D5/D6 DEGs also exhibited a functional dialog with the receptive phase endometrium-specific genes through protein–protein interaction networks, indicating that the embryo undergoes further differentiation for post-implantation development. Furthermore, a modeling strategy using 280 DEGs between blastocysts le","PeriodicalId":13003,"journal":{"name":"Human reproduction","volume":"44 1","pages":""},"PeriodicalIF":6.1,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142444286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Maternal periconception hyperglycemia, preconception diabetes, and risk of major congenital malformations in offspring. 母体围孕期高血糖、孕前糖尿病与后代重大先天畸形的风险。
IF 6.1 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-15 DOI: 10.1093/humrep/deae233
Ran S Rotem,Marc G Weisskopf,Brian Bateman,Krista Huybrechts,Sonia Hernández-Diáz
STUDY QUESTIONWhat are the roles of maternal preconception diabetes and related periconceptional hyperglycemia on the risk of major congenital malformations (MCMs) in offspring?SUMMARY ANSWERMaternal periconceptional glycated hemoglobin (HbA1c) levels over 5.6% were associated with an increased risk of congenital heart defects (CHD) in the offspring, and maternal preconception diabetes was associated with an increased risk of CHD, including when HbA1c levels were within euglycemic ranges.WHAT IS KNOWN ALREADYMaternal preconception diabetes has been linked with MCMs in the offspring. However, evidence concerning associations with specific periconception serum measures of hyperglycemia, and susceptibility of different organ systems, is inconsistent. Moreover, limited evidence exists concerning the effectiveness of antidiabetic medications in mitigating diabetes-related teratogenic risks.STUDY DESIGN, SIZE, DURATIONA large Israeli birth cohort of 46 534 children born in 2001-2020.PARTICIPANTS/MATERIALS, SETTING, METHODSMaternal HbA1c test results were obtained from 90 days before conception to mid-pregnancy. Maternal diabetes, other cardiometabolic conditions, and MCMs in newborns were ascertained based on clinical diagnoses, medication dispensing records, and laboratory test results using previously validated algorithms. Associations were modeled using generalized additive logistic regression models with thin plate penalized splines.MAIN RESULTS AND THE ROLE OF CHANCEMaternal periconceptional HbA1c value was associated with CHD in newborns, with the risk starting to increase at HbA1c values exceeding 5.6%. The association between HbA1c and CHD was stronger among mothers with type 2 diabetes mellitus (T2DM) compared to the other diabetes groups. Maternal pre-existing T2DM was associated with CHD even after accounting for HbA1C levels and other cardiometabolic comorbidities (odds ratio (OR)=1.89, 95% CI 1.18, 3.03); and the OR was materially unchanged when only mothers with pre-existing T2DM who had high adherence to antidiabetic medications and normal HbA1c levels were considered.LIMITATIONS, REASONS FOR CAUTIONThe rarity of some specific malformation groups limited the ability to conduct more granular analyses. The use of HbA1c as a time-aggregated measure of glycemic control may miss transient glycemic dysregulation that could be clinically meaningful for teratogenic risks.WIDER IMPLICATIONS OF THE FINDINGSThe observed association between pre-existing diabetes and the risk of malformations within HbA1c levels suggests underlying causal pathways that are partly independent of maternal glucose control. Therefore, treatments for hyperglycemia might not completely mitigate the teratogenic risk associated with maternal preconception diabetes.STUDY FUNDING/COMPETING INTEREST(S)The work was supported by NIH grants K99ES035433, R01HD097778, and P30ES000002. None of the authors reports competing interests.TRIAL REGISTRATION NUMBERN/A.
研究问题母体孕前糖尿病和相关围孕期高血糖对后代重大先天性畸形(MCMs)风险的作用是什么?6% 与后代患先天性心脏缺陷 (CHD) 的风险增加有关,孕产妇孕前糖尿病与后代患先天性心脏缺陷的风险增加有关,包括 HbA1c 水平在优生优育范围内时。然而,与孕前血清中特定的高血糖指标和不同器官系统的易感性有关的证据并不一致。此外,有关抗糖尿病药物在减轻糖尿病相关致畸风险方面效果的证据也很有限。研究设计、规模、持续时间2001-2020 年间出生的 46 534 名儿童组成的大型以色列出生队列。根据临床诊断、配药记录和实验室检测结果,采用先前验证过的算法确定孕产妇糖尿病、其他心脏代谢疾病和新生儿多器官功能障碍。主要结果和母亲围孕期 HbA1c 值与新生儿冠心病相关,HbA1c 值超过 5.6% 时风险开始增加。与其他糖尿病组别相比,患有 2 型糖尿病(T2DM)的母亲的 HbA1c 值与先天性心脏病之间的关系更为密切。即使考虑了 HbA1C 水平和其他心脏代谢合并症,母亲原有的 T2DM 仍与先天性心脏病有关(几率比(OR)=1.89,95% CI 1.18,3.03);如果只考虑母亲原有的 T2DM,且抗糖尿病药物依从性高、HbA1c 水平正常,则几率比基本不变。使用 HbA1c 作为血糖控制的时间汇总指标可能会漏掉瞬时的血糖失调,而这种失调可能对致畸风险有临床意义。研究结果的广泛影响在 HbA1c 水平范围内观察到的原有糖尿病与畸形风险之间的关联表明,潜在的因果关系部分与母体血糖控制无关。因此,对高血糖的治疗可能无法完全缓解与孕前糖尿病相关的致畸风险。研究经费/竞争利益 本研究得到了美国国立卫生研究院(NIH)K99ES035433、R01HD097778 和 P30ES000002 等基金的支持。所有作者均未报告竞争利益。
{"title":"Maternal periconception hyperglycemia, preconception diabetes, and risk of major congenital malformations in offspring.","authors":"Ran S Rotem,Marc G Weisskopf,Brian Bateman,Krista Huybrechts,Sonia Hernández-Diáz","doi":"10.1093/humrep/deae233","DOIUrl":"https://doi.org/10.1093/humrep/deae233","url":null,"abstract":"STUDY QUESTIONWhat are the roles of maternal preconception diabetes and related periconceptional hyperglycemia on the risk of major congenital malformations (MCMs) in offspring?SUMMARY ANSWERMaternal periconceptional glycated hemoglobin (HbA1c) levels over 5.6% were associated with an increased risk of congenital heart defects (CHD) in the offspring, and maternal preconception diabetes was associated with an increased risk of CHD, including when HbA1c levels were within euglycemic ranges.WHAT IS KNOWN ALREADYMaternal preconception diabetes has been linked with MCMs in the offspring. However, evidence concerning associations with specific periconception serum measures of hyperglycemia, and susceptibility of different organ systems, is inconsistent. Moreover, limited evidence exists concerning the effectiveness of antidiabetic medications in mitigating diabetes-related teratogenic risks.STUDY DESIGN, SIZE, DURATIONA large Israeli birth cohort of 46 534 children born in 2001-2020.PARTICIPANTS/MATERIALS, SETTING, METHODSMaternal HbA1c test results were obtained from 90 days before conception to mid-pregnancy. Maternal diabetes, other cardiometabolic conditions, and MCMs in newborns were ascertained based on clinical diagnoses, medication dispensing records, and laboratory test results using previously validated algorithms. Associations were modeled using generalized additive logistic regression models with thin plate penalized splines.MAIN RESULTS AND THE ROLE OF CHANCEMaternal periconceptional HbA1c value was associated with CHD in newborns, with the risk starting to increase at HbA1c values exceeding 5.6%. The association between HbA1c and CHD was stronger among mothers with type 2 diabetes mellitus (T2DM) compared to the other diabetes groups. Maternal pre-existing T2DM was associated with CHD even after accounting for HbA1C levels and other cardiometabolic comorbidities (odds ratio (OR)=1.89, 95% CI 1.18, 3.03); and the OR was materially unchanged when only mothers with pre-existing T2DM who had high adherence to antidiabetic medications and normal HbA1c levels were considered.LIMITATIONS, REASONS FOR CAUTIONThe rarity of some specific malformation groups limited the ability to conduct more granular analyses. The use of HbA1c as a time-aggregated measure of glycemic control may miss transient glycemic dysregulation that could be clinically meaningful for teratogenic risks.WIDER IMPLICATIONS OF THE FINDINGSThe observed association between pre-existing diabetes and the risk of malformations within HbA1c levels suggests underlying causal pathways that are partly independent of maternal glucose control. Therefore, treatments for hyperglycemia might not completely mitigate the teratogenic risk associated with maternal preconception diabetes.STUDY FUNDING/COMPETING INTEREST(S)The work was supported by NIH grants K99ES035433, R01HD097778, and P30ES000002. None of the authors reports competing interests.TRIAL REGISTRATION NUMBERN/A.","PeriodicalId":13003,"journal":{"name":"Human reproduction","volume":"124 1","pages":""},"PeriodicalIF":6.1,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142443700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impacts of double biopsy and double vitrification on the clinical outcomes following euploid blastocyst transfer: a systematic review and meta-analysis 双活检和双玻璃化对优倍囊胚移植临床结果的影响:系统回顾和荟萃分析
IF 6.1 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-08 DOI: 10.1093/humrep/deae235
Kate Bickendorf, Fang Qi, Kelli Peirce, Rui Wang, Jay Natalwala, Vincent Chapple, Yanhe Liu
STUDY QUESTION Compared to the ‘single biopsy + single vitrification’ approach, do ‘double biopsy + double vitrification’ or ‘single biopsy + double vitrification’ arrangements compromise subsequent clinical outcomes following euploidy blastocyst transfer? SUMMARY ANSWER Both ‘double biopsy + double vitrification’ and ‘single biopsy + double vitrification’ led to reduced live birth/ongoing pregnancy rates and clinical pregnancy rates. WHAT IS KNOWN ALREADY? It is not uncommon to receive inconclusive results following blastocyst biopsy and preimplantation genetic testing for aneuploidy (PGT-A). Often these blastocysts are warmed for re-test after a second biopsy, experiencing ‘double biopsy + double vitrification’. Furthermore, to achieve better workflow, IVF laboratories may choose to routinely vitrify all blastocysts and schedule biopsy at a preferred timing, involving ‘single biopsy + double vitrification’. However, in the current literature, there is a lack of systematic evaluation of both arrangements regarding their potential clinical risks in reference to the most common ‘single biopsy + single vitrification’ approach. STUDY DESIGN, SIZE, DURATION A systematic review and meta-analysis were performed, with the protocol registered in PROSPERO (CRD42023469143). A search in PUBMED, EMBASE, and the Cochrane Library for relevant studies was carried out on 30 August 2023, using the keywords ‘biopsy’ and ‘vitrification’ and associated variations respectively. Only studies involving frozen transfers of PGT-A tested euploid blastocysts were included, with those involving PGT-M or PGT-SR excluded. PARTICIPANTS/MATERIALS, SETTING, METHODS Study groups included blastocysts having undergone ‘double biopsy + double vitrification’ or ‘single biopsy + double vitrification’, with a ‘single biopsy + single vitrification’ group used as control. The primary outcome was clinical pregnancy, while secondary outcomes included live birth/ongoing pregnancy, miscarriage, and post-warming survival rates. Random effects meta-analysis was performed with risk ratios (RR) and 95% CIs were used to present outcome comparisons. MAIN RESULTS AND THE ROLE OF CHANCE A total of 607 records were identified through the initial search and nine studies (six full articles and three abstracts) were eventually included. Compared to ‘single biopsy + single vitrification’, ‘double biopsy + double vitrification’ was associated with reduced clinical pregnancy rates (six studies, n = 18 754; RR = 0.80, 95% CI = 0.71–0.89; I2 = 0%) and live birth/ongoing pregnancy rates (seven studies, n = 20 964; RR = 0.72, 95% CI = 0.63–0.82; I2 = 0%). However, no significant changes were seen in miscarriage rates (seven studies, n = 22 332; RR = 1.40, 95% CI = 0.92–2.11; I2 = 53%) and post-warming survival rates (three studies, n = 13 562; RR = 1.00, 95% CI = 0.99–1.01; I2 = 0%) following ‘double biopsy + double vitrification’. Furthermore, ‘single biopsy + double vitrification’ was also linked with decrea
研究问题 与 "单活检+单玻璃化 "方法相比,"双活检+双玻璃化 "或 "单活检+双玻璃化 "安排是否会影响非整倍体囊胚移植后的临床结果?简答 "双活检+双玻璃化 "和 "单活检+双玻璃化 "都会降低活产率/持续妊娠率和临床妊娠率。已经知道了什么?囊胚活检和植入前非整倍体基因检测(PGT-A)结果不确定的情况并不少见。通常情况下,这些囊胚会在第二次活检后进行再次检测,即 "双重活检 + 双重玻璃化"。此外,为了实现更好的工作流程,IVF 实验室可能会选择对所有囊胚进行常规玻璃化处理,并在首选时间安排活检,即 "单次活检 + 双次玻璃化"。然而,与最常见的 "单次活检 + 单次玻璃化 "方法相比,目前的文献缺乏对这两种安排潜在临床风险的系统评估。研究设计、规模、持续时间 进行了系统性综述和荟萃分析,研究方案已在 PROSPERO(CRD42023469143)上注册。2023 年 8 月 30 日,分别使用关键词 "活检 "和 "玻璃化 "及相关变体在 PUBMED、EMBASE 和 Cochrane 图书馆搜索相关研究。只有涉及冷冻移植 PGT-A 检测过的单倍体囊胚的研究才被纳入,涉及 PGT-M 或 PGT-SR 的研究不包括在内。研究组包括经过 "双活检+双玻璃化 "或 "单活检+双玻璃化 "的囊胚,"单活检+单玻璃化 "组作为对照。主要结果是临床妊娠,次要结果包括活产/继续妊娠、流产和升温后存活率。随机效应荟萃分析采用风险比(RR)和95% CI来进行结果比较。主要结果和偶然性的作用 通过初步搜索共发现了 607 条记录,最终纳入了 9 项研究(6 篇全文和 3 篇摘要)。与 "单活检+单玻璃化 "相比,"双活检+双玻璃化 "与临床妊娠率降低(6 项研究,n = 18 754;RR = 0.80,95% CI = 0.71-0.89;I2 = 0%)和活产/持续妊娠率降低(7 项研究,n = 20 964;RR = 0.72,95% CI = 0.63-0.82;I2 = 0%)有关。然而,在 "双活检+双玻璃化 "后,流产率(7 项研究,n = 22 332;RR = 1.40,95% CI = 0.92-2.11;I2 = 53%)和升温后存活率(3 项研究,n = 13 562;RR = 1.00,95% CI = 0.99-1.01;I2 = 0%)没有明显变化。此外,"单活检+双玻璃化 "还与临床妊娠率下降(6 项研究,n = 13 284;RR = 0.84,95% CI = 0.76-0.92;I2 = 39%)和活产/持续妊娠率下降(7 项研究,n = 16 800;RR = 0.79,95% CI = 0.69-0.91;I2 = 70%)有关。91;I2 = 70%),流产率增加(5 项研究,n = 15 781;RR = 1.48,95% CI = 1.31-1.67;I2 = 0%),但 "单次活检 + 双次玻璃化 "不会影响取暖后存活率(3 项研究,n = 12 452;RR = 0.99,95% CI = 0.97-1.01;I2 = 71%)。局限性、注意事项 本荟萃分析所纳入的所有研究均为回顾性研究,不同结果存在不同程度的异质性。并非所有研究都考虑了潜在的混杂因素。只有一项研究报告了新生儿的结果。研究结果的广泛影响 我们的数据表明,"双活检+双玻璃化 "和 "单活检+双玻璃化 "对极倍体囊胚移植后的临床结果有不利影响。在向患者提供此类方法时,应仔细咨询其风险。活检过程应尽可能谨慎和称职,以减少诊断不明确的情况。研究经费/合作利益 R.W.获得了国家健康与医学研究委员会新兴领导研究者资助(2009767)。没有其他外部资金需要报告。所有作者均未报告利益冲突。注册号:CRD42023469143。
{"title":"Impacts of double biopsy and double vitrification on the clinical outcomes following euploid blastocyst transfer: a systematic review and meta-analysis","authors":"Kate Bickendorf, Fang Qi, Kelli Peirce, Rui Wang, Jay Natalwala, Vincent Chapple, Yanhe Liu","doi":"10.1093/humrep/deae235","DOIUrl":"https://doi.org/10.1093/humrep/deae235","url":null,"abstract":"STUDY QUESTION Compared to the ‘single biopsy + single vitrification’ approach, do ‘double biopsy + double vitrification’ or ‘single biopsy + double vitrification’ arrangements compromise subsequent clinical outcomes following euploidy blastocyst transfer? SUMMARY ANSWER Both ‘double biopsy + double vitrification’ and ‘single biopsy + double vitrification’ led to reduced live birth/ongoing pregnancy rates and clinical pregnancy rates. WHAT IS KNOWN ALREADY? It is not uncommon to receive inconclusive results following blastocyst biopsy and preimplantation genetic testing for aneuploidy (PGT-A). Often these blastocysts are warmed for re-test after a second biopsy, experiencing ‘double biopsy + double vitrification’. Furthermore, to achieve better workflow, IVF laboratories may choose to routinely vitrify all blastocysts and schedule biopsy at a preferred timing, involving ‘single biopsy + double vitrification’. However, in the current literature, there is a lack of systematic evaluation of both arrangements regarding their potential clinical risks in reference to the most common ‘single biopsy + single vitrification’ approach. STUDY DESIGN, SIZE, DURATION A systematic review and meta-analysis were performed, with the protocol registered in PROSPERO (CRD42023469143). A search in PUBMED, EMBASE, and the Cochrane Library for relevant studies was carried out on 30 August 2023, using the keywords ‘biopsy’ and ‘vitrification’ and associated variations respectively. Only studies involving frozen transfers of PGT-A tested euploid blastocysts were included, with those involving PGT-M or PGT-SR excluded. PARTICIPANTS/MATERIALS, SETTING, METHODS Study groups included blastocysts having undergone ‘double biopsy + double vitrification’ or ‘single biopsy + double vitrification’, with a ‘single biopsy + single vitrification’ group used as control. The primary outcome was clinical pregnancy, while secondary outcomes included live birth/ongoing pregnancy, miscarriage, and post-warming survival rates. Random effects meta-analysis was performed with risk ratios (RR) and 95% CIs were used to present outcome comparisons. MAIN RESULTS AND THE ROLE OF CHANCE A total of 607 records were identified through the initial search and nine studies (six full articles and three abstracts) were eventually included. Compared to ‘single biopsy + single vitrification’, ‘double biopsy + double vitrification’ was associated with reduced clinical pregnancy rates (six studies, n = 18 754; RR = 0.80, 95% CI = 0.71–0.89; I2 = 0%) and live birth/ongoing pregnancy rates (seven studies, n = 20 964; RR = 0.72, 95% CI = 0.63–0.82; I2 = 0%). However, no significant changes were seen in miscarriage rates (seven studies, n = 22 332; RR = 1.40, 95% CI = 0.92–2.11; I2 = 53%) and post-warming survival rates (three studies, n = 13 562; RR = 1.00, 95% CI = 0.99–1.01; I2 = 0%) following ‘double biopsy + double vitrification’. Furthermore, ‘single biopsy + double vitrification’ was also linked with decrea","PeriodicalId":13003,"journal":{"name":"Human reproduction","volume":"33 1","pages":""},"PeriodicalIF":6.1,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142385650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protective effects of engineered Lactobacillus crispatus strains expressing G-CSF on thin endometrium of mice. 表达 G-CSF 的脆片乳杆菌工程菌株对小鼠薄子宫内膜的保护作用。
IF 6 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-01 DOI: 10.1093/humrep/deae190
Shuang Liu, Yingnan Zhang, Xin Ma, Chenglin Zhan, Ning Ding, Mai Shi, Wei Zhang, Shubao Yang
<p><strong>Study question: </strong>Does recombinant Lactobacillus expressing granulocyte colony-stimulating factor (G-CSF) have a better protective effect than the current treatment of thin endometrium (TE)?</p><p><strong>Summary answer: </strong>This study suggested that the intrauterine injection of Lactobacillus crispastus (L. crispastus)-pPG612-G-CSF has a positive effect on preventing TE induced by 95% alcohol in mice.</p><p><strong>What is known already: </strong>TE has a negative impact on the success rate of ART in patients, and is usually caused by intrauterine surgery, endometrial infection, or hormone drugs. Exogenous G-CSF can promote endometrial vascular remodelling and increase endometrial receptivity and the embryo implantation rate. Moreover, Lactobacillus plays a crucial role in maintaining and regulating the local microecological balance of the reproductive tract, and it could be a delivery carrier of the endometrial repair drug G-CSF.</p><p><strong>Study design, size, duration: </strong>We constructed engineered L. crispastus strains expressing G-CSF. The mice were divided into five groups: (i) Control group (C, n = 28), uteri were treated with preheated saline solution via intrauterine injection on the third and sixth day of oestrus; (ii) Model group (M, n = 35), where uteri were treated with 95% alcohol on the third day of oestrus and preheated saline solution on the sixth day of oestrus via intrauterine injection; (iii) L. crispatus-pPG612-treatment group (L, n = 45), where uteri were treated with 95% alcohol on the third day of oestrus and 0.1 ml × 108 CFU/ml L. crispatus-pPG612 on the sixth day of oestrus via intrauterine injection; (iv) L. crispatus-pPG612-treatment group (LG, n = 45), where uteri were treated with 95% alcohol on the third day of oestrus and 0.1 ml × 108 CFU/ml L. crispatus-pPG612-G-CSF on the sixth day of oestrus via intrauterine injection; (v) G-CSF-treatment group (G, n = 52), where uteri were treated with 95% alcohol on the third day of oestrus and 30 µg/kg G-CSF on the sixth day of oestrus via intrauterine injection. Then, we compared the effects of L. crispastus, L. crispatus-pPG612-G-CSF and G-CSF on endometrial thickness, angiogenesis, fibrosis, and inflammation in the TE mouse.</p><p><strong>Participants/materials, setting, methods: </strong>We collected uterine tissues for haematoxylin-eosin staining, immunohistochemical staining, Western blot and RT-PCR, as well as serum for ELISA and uterine flushing solution for high-throughput sequencing.</p><p><strong>Main results and the role of chance: </strong>Compared with those in the M group (the mice of the group were intrauterine injected 95% alcohol and treated with saline solution), the L. crispatus-pPG612-G-CSF strain increased the thickness of the endometrium (P < 0.001) and the number of blood vessels and glands (both P < 0.001), enhanced the expression of cytokeratin 19 (CK19) (P < 0.001), vimentin (Vim) (P < 0.001), vascular endothelial grow
研究问题:表达粒细胞集落刺激因子(G-CSF)的重组乳杆菌是否比目前治疗子宫内膜薄(TE)的方法具有更好的保护作用?本研究表明,宫腔内注射脆化乳杆菌(L. crispastus)-pPG612-G-CSF对预防95%酒精诱导的小鼠TE有积极作用:TE对患者抗逆转录病毒疗法的成功率有负面影响,通常由宫腔内手术、子宫内膜感染或激素药物引起。外源性 G-CSF 可促进子宫内膜血管重塑,提高子宫内膜接受性和胚胎着床率。此外,乳酸杆菌在维持和调节生殖道局部微生态平衡方面发挥着重要作用,可作为子宫内膜修复药物 G-CSF 的输送载体:研究设计、规模、持续时间:我们构建了表达G-CSF的L. crispastus工程菌株。小鼠分为五组:(i) 对照组(C,n = 28),在发情第三天和第六天通过宫腔注射预热生理盐水处理子宫;(ii) 模型组(M,n = 35),在发情第三天用 95% 酒精处理子宫,在发情第六天通过宫腔注射预热生理盐水处理子宫;(iii) L. crispatus-pPG612-t 组,在发情第三天用 95% 酒精处理子宫,在发情第六天通过宫腔注射预热生理盐水处理子宫。pPG612处理组(L,n = 45),发情第三天用95%酒精处理子宫,发情第六天宫内注射0.1 ml × 108 CFU/ml L. crispatus-pPG612 通过宫内注射;(iv) L. crispatus-pPG612 处理组(LG,n = 45),发情第三天用 95% 的酒精处理子宫,发情第六天用 0.1 ml × 108 CFU/ml L. crispatus-pPG612-G 处理子宫。(v) G-CSF 处理组(G,n = 52),发情第三天用 95% 酒精处理子宫,发情第六天宫内注射 30 µg/kg G-CSF。然后,我们比较了L. crispastus、L. crispatus-pPG612-G-CSF和G-CSF对TE小鼠子宫内膜厚度、血管生成、纤维化和炎症的影响:我们采集了子宫组织进行血栓素-伊红染色、免疫组化染色、Western blot和RT-PCR,还采集了血清进行ELISA和子宫冲洗液进行高通量测序:与 M 组(该组小鼠宫内注射 95% 酒精并用生理盐水处理)相比,L. crispatus-pPG612-G-CSF 菌株增加了子宫内膜厚度(P 大比例尺数据):不适用:L.crispatus-pPG612-G-CSF菌株疗法在加速TE的修复过程方面具有巨大潜力。然而,我们仅报告了与PI3K/AKT通路相关的基因和蛋白的表达,L. crispatus-pPG612-G-CSF对子宫内膜的修复可能还涉及许多其他机制:该研究结果为 TE 的治疗提供了新思路和新方法:本研究得到了吉林省科技发展计划项目(批准号:20210101232JC)、吉林省教育厅科技计划项目(批准号:JT53101022010)和吉林医科大学博士科研启动基金(批准号:JYBS2021014LK和2022JYBS006KJ)的资助。作者声明,研究过程中不存在任何可能被视为潜在利益冲突的商业或经济关系。
{"title":"Protective effects of engineered Lactobacillus crispatus strains expressing G-CSF on thin endometrium of mice.","authors":"Shuang Liu, Yingnan Zhang, Xin Ma, Chenglin Zhan, Ning Ding, Mai Shi, Wei Zhang, Shubao Yang","doi":"10.1093/humrep/deae190","DOIUrl":"10.1093/humrep/deae190","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Study question: &lt;/strong&gt;Does recombinant Lactobacillus expressing granulocyte colony-stimulating factor (G-CSF) have a better protective effect than the current treatment of thin endometrium (TE)?&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Summary answer: &lt;/strong&gt;This study suggested that the intrauterine injection of Lactobacillus crispastus (L. crispastus)-pPG612-G-CSF has a positive effect on preventing TE induced by 95% alcohol in mice.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;What is known already: &lt;/strong&gt;TE has a negative impact on the success rate of ART in patients, and is usually caused by intrauterine surgery, endometrial infection, or hormone drugs. Exogenous G-CSF can promote endometrial vascular remodelling and increase endometrial receptivity and the embryo implantation rate. Moreover, Lactobacillus plays a crucial role in maintaining and regulating the local microecological balance of the reproductive tract, and it could be a delivery carrier of the endometrial repair drug G-CSF.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Study design, size, duration: &lt;/strong&gt;We constructed engineered L. crispastus strains expressing G-CSF. The mice were divided into five groups: (i) Control group (C, n = 28), uteri were treated with preheated saline solution via intrauterine injection on the third and sixth day of oestrus; (ii) Model group (M, n = 35), where uteri were treated with 95% alcohol on the third day of oestrus and preheated saline solution on the sixth day of oestrus via intrauterine injection; (iii) L. crispatus-pPG612-treatment group (L, n = 45), where uteri were treated with 95% alcohol on the third day of oestrus and 0.1 ml × 108 CFU/ml L. crispatus-pPG612 on the sixth day of oestrus via intrauterine injection; (iv) L. crispatus-pPG612-treatment group (LG, n = 45), where uteri were treated with 95% alcohol on the third day of oestrus and 0.1 ml × 108 CFU/ml L. crispatus-pPG612-G-CSF on the sixth day of oestrus via intrauterine injection; (v) G-CSF-treatment group (G, n = 52), where uteri were treated with 95% alcohol on the third day of oestrus and 30 µg/kg G-CSF on the sixth day of oestrus via intrauterine injection. Then, we compared the effects of L. crispastus, L. crispatus-pPG612-G-CSF and G-CSF on endometrial thickness, angiogenesis, fibrosis, and inflammation in the TE mouse.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Participants/materials, setting, methods: &lt;/strong&gt;We collected uterine tissues for haematoxylin-eosin staining, immunohistochemical staining, Western blot and RT-PCR, as well as serum for ELISA and uterine flushing solution for high-throughput sequencing.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main results and the role of chance: &lt;/strong&gt;Compared with those in the M group (the mice of the group were intrauterine injected 95% alcohol and treated with saline solution), the L. crispatus-pPG612-G-CSF strain increased the thickness of the endometrium (P &lt; 0.001) and the number of blood vessels and glands (both P &lt; 0.001), enhanced the expression of cytokeratin 19 (CK19) (P &lt; 0.001), vimentin (Vim) (P &lt; 0.001), vascular endothelial grow","PeriodicalId":13003,"journal":{"name":"Human reproduction","volume":" ","pages":"2305-2319"},"PeriodicalIF":6.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142043926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply: Doppler ultrasound and first trimester pregnancy: not always a happy marriage. 回复:多普勒超声和怀孕头三个月:并不总是幸福的婚姻。
IF 6 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-01 DOI: 10.1093/humrep/deae177
E S de Vos, A G M G J Mulders, A H J Koning, S P Willemsen, M Rousian, B B van Rijn, E A P Steegers, R P M Steegers-Theunissen
{"title":"Reply: Doppler ultrasound and first trimester pregnancy: not always a happy marriage.","authors":"E S de Vos, A G M G J Mulders, A H J Koning, S P Willemsen, M Rousian, B B van Rijn, E A P Steegers, R P M Steegers-Theunissen","doi":"10.1093/humrep/deae177","DOIUrl":"10.1093/humrep/deae177","url":null,"abstract":"","PeriodicalId":13003,"journal":{"name":"Human reproduction","volume":" ","pages":"2372"},"PeriodicalIF":6.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142046617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of embryologist stress, somatization, and burnout reported by embryologists working in UK HFEA-licensed ART/IVF clinics and USA ART/IVF clinics. 比较在英国 HFEA 许可的 ART/IVF 诊所和美国 ART/IVF 诊所工作的胚胎学家报告的胚胎学家压力、躯体化和职业倦怠情况。
IF 6 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-01 DOI: 10.1093/humrep/deae191
Anar Murphy, Mark S Lapczynski, Glenn Proctor, Timothy R Glynn, Alice D Domar, Sofia Gameiro, Giles A Palmer, Michael G Collins
<p><strong>Study question: </strong>What is the prevalence of occupational stress, somatization, and burnout reported by UK and US, embryologists and the impact of work conditions on these well-being outcomes?</p><p><strong>Summary answer: </strong>Surveyed UK and US embryologists reported moderate perceived stress, low somatic symptom severity, high levels of burnout, and overall stressful work conditions, but with differences that could be due to country-specific occupational and employment characteristics.</p><p><strong>What is known already?: </strong>Spanish, UK, US, and international surveys have identified high levels of occupational stress, somatization, burnout, and occupational health issues among embryologists. These issues have been attributed to embryologists' occupational challenges and work conditions.</p><p><strong>Study design, size, duration: </strong>A cross-sectional web-based survey was sent to 253 embryologists working in UK ART/IVF clinics and 487 embryologists working in US ART/IVF clinics.</p><p><strong>Participants/materials, setting, methods: </strong>Participants self-reported their stress levels, somatization, burnout, and work conditions. Proportions across the Perceived Stress Scale (PSS), Patient Health Questionnaire (PHQ-15), Maslach Burnout Inventory-General Survey (MBI-GS), a single-item work unit grade (A-F), and customized occupational and sociodemographic questionnaires were calculated using descriptive statistics. Welch's t-test was utilized to compare PSS and PHQ-15 scores between groups. Risk ratios were calculated using log-binomial regression for all models except for levels of anxiety related to performing cryostorage tasks, for which Poisson models were used.</p><p><strong>Main results and the role of chance: </strong>In total, 50.6% (128) of the embryologists in the UK and 50.1% (244) in the US completed the survey. Both groups self-reported moderate PSS and low PHQ-15 scores, although fewer UK embryologists scored high on the MBI cynicism dimension than their US colleagues (43% UK vs 60% US embryologists, P < 0.05). The UK and US embryologists did not differ on the MBI exhaustion dimension with both scoring high for exhaustion (59% UK vs 62% US). Although 81% and 80% of UK and US embryologists, respectively, reported working overtime, more embryologists in the UK reported being adequately compensated. Increasing levels of anxiety-related to cryostorage showed a dose-dependent increased risk of burnout on at least two MBI-GS dimensions only in the UK group, and, a dose-dependent likelihood of higher PSS and PHQ-15 scores in both groups.</p><p><strong>Limitations, reasons for caution: </strong>Since the two groups were surveyed 9 months apart and were self-reporting, the study is limited by the differences in responsibilities, scheduling, and workload specific to the time of year.</p><p><strong>Wider implications of the findings: </strong>Work-related health issues and occupational challenges shared by
研究问题:英国和美国胚胎学家报告的职业压力、躯体化和职业倦怠的发生率如何,以及工作条件对这些幸福结果的影响?接受调查的英国和美国胚胎学家报告了中等程度的感知压力、较低的躯体症状严重性、较高水平的职业倦怠和总体压力较大的工作条件,但可能因国家特定的职业和就业特点而存在差异:西班牙、英国、美国和国际调查发现,胚胎学家的职业压力、躯体化、职业倦怠和职业健康问题都很严重。这些问题归因于胚胎学家的职业挑战和工作条件:对在英国 ART/IVF 诊所工作的 253 名胚胎学家和在美国 ART/IVF 诊所工作的 487 名胚胎学家进行了横断面网络调查:参与者自我报告了他们的压力水平、躯体化、职业倦怠和工作条件。采用描述性统计方法计算了感知压力量表(PSS)、患者健康问卷(PHQ-15)、马斯拉赫职业倦怠调查表(MBI-GS)、单项工作单位等级(A-F)以及定制的职业和社会人口问卷的比例。采用韦尔奇 t 检验比较不同组间的 PSS 和 PHQ-15 分数。除与执行低温贮藏任务相关的焦虑水平采用泊松模型外,所有模型均采用对数二项式回归法计算风险比:共有 50.6% 的英国胚胎学家(128 人)和 50.1% 的美国胚胎学家(244 人)完成了调查。两组胚胎学家均自称PSS评分中等,PHQ-15评分较低,但在MBI愤世嫉俗维度上得分较高的英国胚胎学家少于美国同行(43%的英国胚胎学家对60%的美国胚胎学家,P 限制、谨慎的原因):由于两组人的调查时间相隔 9 个月,而且都是自我报告,因此研究受到了一年中特定时间的责任、日程安排和工作量差异的限制:研究结果的广泛意义:英国和美国胚胎学家共同面临的与工作相关的健康问题和职业挑战可以通过组织改进和技术来解决。英国胚胎学家的压力和倦怠程度较低,可能是由于HFEA提供的结构/确定性:该公司正在开发胚胎学自动化平台并将其商业化。M.G.C. 和 M.S.L. 是 TMRW 生命科学公司的全职员工和股东,Novavax 公司的 A.M. 是 TMRW 生命科学公司的员工。G.P. 是 TMRW 生命科学公司的顾问。其余作者声明无利益冲突:NCT05326802;NCT05708963。
{"title":"Comparison of embryologist stress, somatization, and burnout reported by embryologists working in UK HFEA-licensed ART/IVF clinics and USA ART/IVF clinics.","authors":"Anar Murphy, Mark S Lapczynski, Glenn Proctor, Timothy R Glynn, Alice D Domar, Sofia Gameiro, Giles A Palmer, Michael G Collins","doi":"10.1093/humrep/deae191","DOIUrl":"10.1093/humrep/deae191","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Study question: &lt;/strong&gt;What is the prevalence of occupational stress, somatization, and burnout reported by UK and US, embryologists and the impact of work conditions on these well-being outcomes?&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Summary answer: &lt;/strong&gt;Surveyed UK and US embryologists reported moderate perceived stress, low somatic symptom severity, high levels of burnout, and overall stressful work conditions, but with differences that could be due to country-specific occupational and employment characteristics.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;What is known already?: &lt;/strong&gt;Spanish, UK, US, and international surveys have identified high levels of occupational stress, somatization, burnout, and occupational health issues among embryologists. These issues have been attributed to embryologists' occupational challenges and work conditions.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Study design, size, duration: &lt;/strong&gt;A cross-sectional web-based survey was sent to 253 embryologists working in UK ART/IVF clinics and 487 embryologists working in US ART/IVF clinics.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Participants/materials, setting, methods: &lt;/strong&gt;Participants self-reported their stress levels, somatization, burnout, and work conditions. Proportions across the Perceived Stress Scale (PSS), Patient Health Questionnaire (PHQ-15), Maslach Burnout Inventory-General Survey (MBI-GS), a single-item work unit grade (A-F), and customized occupational and sociodemographic questionnaires were calculated using descriptive statistics. Welch's t-test was utilized to compare PSS and PHQ-15 scores between groups. Risk ratios were calculated using log-binomial regression for all models except for levels of anxiety related to performing cryostorage tasks, for which Poisson models were used.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main results and the role of chance: &lt;/strong&gt;In total, 50.6% (128) of the embryologists in the UK and 50.1% (244) in the US completed the survey. Both groups self-reported moderate PSS and low PHQ-15 scores, although fewer UK embryologists scored high on the MBI cynicism dimension than their US colleagues (43% UK vs 60% US embryologists, P &lt; 0.05). The UK and US embryologists did not differ on the MBI exhaustion dimension with both scoring high for exhaustion (59% UK vs 62% US). Although 81% and 80% of UK and US embryologists, respectively, reported working overtime, more embryologists in the UK reported being adequately compensated. Increasing levels of anxiety-related to cryostorage showed a dose-dependent increased risk of burnout on at least two MBI-GS dimensions only in the UK group, and, a dose-dependent likelihood of higher PSS and PHQ-15 scores in both groups.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Limitations, reasons for caution: &lt;/strong&gt;Since the two groups were surveyed 9 months apart and were self-reporting, the study is limited by the differences in responsibilities, scheduling, and workload specific to the time of year.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Wider implications of the findings: &lt;/strong&gt;Work-related health issues and occupational challenges shared by","PeriodicalId":13003,"journal":{"name":"Human reproduction","volume":" ","pages":"2297-2304"},"PeriodicalIF":6.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11447060/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142092811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimized personalized management approach for moderate/severe OHSS: development and prospective validation of an OHSS risk assessment index. 中度/重度OHSS的优化个性化管理方法:OHSS风险评估指数的开发和前瞻性验证。
IF 6 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-01 DOI: 10.1093/humrep/deae197
Mingzhu Cao, Qiwang Lin, Zhi Liu, Yanshan Lin, Qing Huang, Yang Fu, Yang Zhang, Hang Shi, Chongyang Duan, Haiying Liu, Jianqiao Liu
<p><strong>Study question: </strong>Can a simplified ovarian hyperstimulation syndrome (OHSS) risk assessment index be developed and validated with sufficient discrimination of moderate/severe OHSS from those without OHSS?</p><p><strong>Summary answer: </strong>This easy-to-use OHSS risk assessment index shows good discriminative power and high calibration accuracy in internal and external validation cohorts.</p><p><strong>What is known already: </strong>An early alert and risk stratification is critical to prevent the occurrence of OHSS. We have previously developed a multi-stage smartphone app-based prediction model to evaluate the risk of OHSS, but app use might not be so convenient in many primary institutions. A simplified OHSS risk assessment index has been required.</p><p><strong>Study design, size, duration: </strong>This training and internal validation of an OHSS risk assessment index used retrospective cohort data from January 2016 to December 2020. External validation was performed with a prospective cohort database from January 2021 to May 2022. There were 15 066 cycles in the training cohort, 6502 cycles in the internal validation cohort, and 8097 cycles in the external validation cohort.</p><p><strong>Participants/materials, setting, methods: </strong>This study was performed in the reproductive medicine center of a tertiary hospital. Infertile women who underwent ovarian stimulation were included. Data were extracted from the local database with detailed medical records. A multi-stage risk assessment index was constructed at multiple stages. The first stage was before the initiation of ovarian stimulation, the second was before the ovulation trigger, the third was after oocyte retrieval, and the last stage was on the embryo transfer day if fresh embryo transfer was scheduled.</p><p><strong>Main results and the role of chance: </strong>We established a simplified multi-stage risk assessment index for moderate/severe OHSS, the performance of which was further evaluated with discrimination and calibration abilities in training and internal and external validation cohorts. The discrimination abilities of the OHSS risk assessment index were determined with C-statistics. C-statistics in training (Stages 1-4: 0.631, 0.692, 0.751, 0.788, respectively) and internal (Stages 1-4: 0.626, 0.642, 0.755, 0.771, respectively) and external validation (Stages 1-4: 0.668, 0.670, 0.754, 0.773, respectively) cohorts were all increased from Stage 1 to 3 with similar trends, and were comparable between Stages 3 and 4. Calibration plots showed high agreement between observed and predicted cases in all three cohorts. Incidences of OHSS based on diverse risk stratification (negligible risk, low risk, medium risk, and high risk) were 0%, 0.6%, 2.7%, and 8.3% in the training cohort, 0%, 0.6%, 3.3%, and 8.5% in the internal validation cohort, and 0.1%, 1.1%, 4.1%, and 7.2% in the external validation cohort.</p><p><strong>Limitations, reasons for caution: </st
研究问题:能否开发并验证一种简化的卵巢过度刺激综合征(OHSS)风险评估指数,以充分区分中度/重度OHSS和无OHSS患者?这一易于使用的卵巢过度刺激综合征风险评估指数在内部和外部验证队列中显示出良好的鉴别力和较高的校准准确性:早期预警和风险分层对于预防 OHSS 的发生至关重要。我们之前开发了一个基于智能手机应用程序的多阶段预测模型来评估OHSS风险,但在许多基层医疗机构,使用应用程序可能并不那么方便。我们需要一个简化的OHSS风险评估指标:本次OHSS风险评估指数的培训和内部验证使用了2016年1月至2020年12月的回顾性队列数据。外部验证使用的是 2021 年 1 月至 2022 年 5 月的前瞻性队列数据库。培训队列中有 15 066 个周期,内部验证队列中有 6502 个周期,外部验证队列中有 8097 个周期:本研究在一家三甲医院的生殖医学中心进行。研究对象包括接受卵巢刺激的不孕妇女。数据来自当地数据库的详细医疗记录。在多个阶段构建了多阶段风险评估指数。第一阶段为卵巢刺激开始前,第二阶段为排卵触发前,第三阶段为取卵后,最后一个阶段为胚胎移植日(如果安排了鲜胚移植):我们建立了一个简化的中度/重度OHSS多阶段风险评估指标,并通过训练队列、内部和外部验证队列的判别和校准能力对该指标的性能进行了进一步评估。OHSS风险评估指数的判别能力由C统计量决定。训练队列(第 1-4 阶段:分别为 0.631、0.692、0.751、0.788)和内部验证队列(第 1-4 阶段:分别为 0.626、0.642、0.755、0.771)及外部验证队列(第 1-4 阶段:分别为 0.668、0.670、0.754、0.773)的 C 统计量从第 1 阶段到第 3 阶段均呈上升趋势,且第 3 阶段和第 4 阶段之间的趋势相似。校准图显示,在所有三个队列中,观察病例与预测病例之间的一致性很高。根据不同的风险分层(可忽略风险、低风险、中风险和高风险),OHSS 的发生率在训练队列中分别为 0%、0.6%、2.7% 和 8.3%,在内部验证队列中分别为 0%、0.6%、3.3% 和 8.5%,在外部验证队列中分别为 0.1%、1.1%、4.1% 和 7.2%:不能排除临床干预(包括冷冻保存所有胚胎)的影响,因此某些风险因素(如触发日的雌激素水平)可能会被赋予较低的风险评分。该研究的另一个不足之处是,模型中没有记录和评估几种预防性治疗,如口服阿司匹林和来曲唑。尽管OHSS评估指数非常可靠,但该工具不能直接用于临床决策或作为诊断工具。它的价值在于能够评估各种干预措施的预后,并促进临床医生与患者之间的沟通。应将这一工具与进一步的症状和检查结合起来考虑,以便对 OHSS 进行准确和个性化的管理:研究结果的广泛意义:OHSS风险评估指数可用于促进OHSS的个性化咨询和管理:本研究得到了国家重点研发计划(2022YFC2702504)、广东省医学科研基金(A2024003)和广东省支援新疆农村科技(特派员)计划(KTPYJ 2023014)的支持。所有作者均未披露任何信息:不详。
{"title":"Optimized personalized management approach for moderate/severe OHSS: development and prospective validation of an OHSS risk assessment index.","authors":"Mingzhu Cao, Qiwang Lin, Zhi Liu, Yanshan Lin, Qing Huang, Yang Fu, Yang Zhang, Hang Shi, Chongyang Duan, Haiying Liu, Jianqiao Liu","doi":"10.1093/humrep/deae197","DOIUrl":"10.1093/humrep/deae197","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Study question: &lt;/strong&gt;Can a simplified ovarian hyperstimulation syndrome (OHSS) risk assessment index be developed and validated with sufficient discrimination of moderate/severe OHSS from those without OHSS?&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Summary answer: &lt;/strong&gt;This easy-to-use OHSS risk assessment index shows good discriminative power and high calibration accuracy in internal and external validation cohorts.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;What is known already: &lt;/strong&gt;An early alert and risk stratification is critical to prevent the occurrence of OHSS. We have previously developed a multi-stage smartphone app-based prediction model to evaluate the risk of OHSS, but app use might not be so convenient in many primary institutions. A simplified OHSS risk assessment index has been required.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Study design, size, duration: &lt;/strong&gt;This training and internal validation of an OHSS risk assessment index used retrospective cohort data from January 2016 to December 2020. External validation was performed with a prospective cohort database from January 2021 to May 2022. There were 15 066 cycles in the training cohort, 6502 cycles in the internal validation cohort, and 8097 cycles in the external validation cohort.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Participants/materials, setting, methods: &lt;/strong&gt;This study was performed in the reproductive medicine center of a tertiary hospital. Infertile women who underwent ovarian stimulation were included. Data were extracted from the local database with detailed medical records. A multi-stage risk assessment index was constructed at multiple stages. The first stage was before the initiation of ovarian stimulation, the second was before the ovulation trigger, the third was after oocyte retrieval, and the last stage was on the embryo transfer day if fresh embryo transfer was scheduled.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main results and the role of chance: &lt;/strong&gt;We established a simplified multi-stage risk assessment index for moderate/severe OHSS, the performance of which was further evaluated with discrimination and calibration abilities in training and internal and external validation cohorts. The discrimination abilities of the OHSS risk assessment index were determined with C-statistics. C-statistics in training (Stages 1-4: 0.631, 0.692, 0.751, 0.788, respectively) and internal (Stages 1-4: 0.626, 0.642, 0.755, 0.771, respectively) and external validation (Stages 1-4: 0.668, 0.670, 0.754, 0.773, respectively) cohorts were all increased from Stage 1 to 3 with similar trends, and were comparable between Stages 3 and 4. Calibration plots showed high agreement between observed and predicted cases in all three cohorts. Incidences of OHSS based on diverse risk stratification (negligible risk, low risk, medium risk, and high risk) were 0%, 0.6%, 2.7%, and 8.3% in the training cohort, 0%, 0.6%, 3.3%, and 8.5% in the internal validation cohort, and 0.1%, 1.1%, 4.1%, and 7.2% in the external validation cohort.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Limitations, reasons for caution: &lt;/st","PeriodicalId":13003,"journal":{"name":"Human reproduction","volume":" ","pages":"2320-2330"},"PeriodicalIF":6.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142139891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single-cell RNA sequencing reveals transcriptomic landscape and potential targets for human testicular ageing. 单细胞 RNA 测序揭示人类睾丸老化的转录组格局和潜在靶标
IF 6 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-01 DOI: 10.1093/humrep/deae199
Kai Xia, Peng Luo, Jiajie Yu, Siyuan He, Lin Dong, Feng Gao, Xuren Chen, Yunlin Ye, Yong Gao, Yuanchen Ma, Cuifeng Yang, Yadong Zhang, Qiyun Yang, Dayu Han, Xin Feng, Zi Wan, Hongcai Cai, Qiong Ke, Tao Wang, Weiqiang Li, Xiang'an Tu, Xiangzhou Sun, Chunhua Deng, Andy Peng Xiang
<p><strong>Study question: </strong>What is the molecular landscape underlying the functional decline of human testicular ageing?</p><p><strong>Summary answer: </strong>The present study provides a comprehensive single-cell transcriptomic atlas of testes from young and old humans and offers insights into the molecular mechanisms and potential targets for human testicular ageing.</p><p><strong>What is known already: </strong>Testicular ageing is known to cause male age-related fertility decline and hypogonadism. Dysfunction of testicular cells has been considered as a key factor for testicular ageing.</p><p><strong>Study design, size, duration: </strong>Human testicular biopsies were collected from three young individuals and three old individuals to perform single-cell RNA sequencing (scRNA-seq). The key results were validated in a larger cohort containing human testicular samples from 10 young donors and 10 old donors.</p><p><strong>Participants/materials, setting, methods: </strong>scRNA-seq was used to identify gene expression signatures for human testicular cells during ageing. Ageing-associated changes of gene expression in spermatogonial stem cells (SSCs) and Leydig cells (LCs) were analysed by gene set enrichment analysis and validated by immunofluorescent and functional assays. Cell-cell communication analysis was performed using CellChat.</p><p><strong>Main results and the role of chance: </strong>The single-cell transcriptomic landscape of testes from young and old men was surveyed, revealing age-related changes in germline and somatic niche cells. In-depth evaluation of the gene expression dynamics in germ cells revealed that the disruption of the base-excision repair pathway is a prominent characteristic of old SSCs, suggesting that defective DNA repair in SSCs may serve as a potential driver for increased de novo germline mutations with age. Further analysis of ageing-associated transcriptional changes demonstrated that stress-related changes and cytokine pathways accumulate in old somatic cells. Age-related impairment of redox homeostasis in old LCs was identified and pharmacological treatment with antioxidants alleviated this cellular dysfunction of LCs and promoted testosterone production. Lastly, our results revealed that decreased pleiotrophin signalling was a contributing factor for impaired spermatogenesis in testicular ageing.</p><p><strong>Large scale data: </strong>The scRNA-seq sequencing and processed data reported in this paper were deposited at the Genome Sequence Archive (https://ngdc.cncb.ac.cn/), under the accession number HRA002349.</p><p><strong>Limitations, reasons for caution: </strong>Owing to the difficulty in collecting human testis tissue, the sample size was limited. Further in-depth functional and mechanistic studies are warranted in future.</p><p><strong>Wider implications of the findings: </strong>These findings provide a comprehensive understanding of the cell type-specific mechanisms underlying human te
研究问题:人类睾丸老化功能衰退的分子基础是什么?本研究提供了年轻和年老人类睾丸的全面单细胞转录组图谱,为人类睾丸老化的分子机制和潜在靶点提供了见解:众所周知,睾丸老化会导致男性与年龄相关的生育能力下降和性腺功能减退。睾丸细胞功能障碍被认为是睾丸老化的关键因素:研究设计、规模和持续时间:分别从三个年轻人和三个老年人身上采集人体睾丸活检样本,进行单细胞 RNA 测序(scRNA-seq)。参与者/材料、环境、方法:利用 scRNA-seq 鉴定人类睾丸细胞在衰老过程中的基因表达特征。通过基因组富集分析法分析了精原干细胞(SSCs)和莱迪格细胞(LCs)中与衰老相关的基因表达变化,并通过免疫荧光和功能测试进行了验证。主要结果和偶然性的作用:研究人员调查了年轻男性和老年男性睾丸的单细胞转录组图谱,揭示了生殖细胞和体细胞龛细胞与年龄有关的变化。对生殖细胞基因表达动态的深入评估发现,碱基切除修复途径的破坏是老年生殖细胞的一个显著特征,这表明生殖细胞的DNA修复缺陷可能是随着年龄增长生殖突变增加的潜在驱动因素。对衰老相关转录变化的进一步分析表明,应激相关变化和细胞因子通路在老年体细胞中累积。研究还发现,衰老体细胞的氧化还原平衡受到了与年龄相关的损害,抗氧化剂的药物治疗缓解了衰老体细胞的细胞功能障碍,并促进了睾酮的产生。最后,我们的研究结果表明,多营养素信号的减少是睾丸老化过程中精子发生受损的一个因素:本文报告的scRNA-seq测序和处理数据已存入基因组序列档案(https://ngdc.cncb.ac.cn/),登录号为HRA002349。局限性和需要谨慎的原因:由于难以收集人类睾丸组织,样本量有限。研究结果的广泛影响:这些研究结果为全面了解人类睾丸组织的功能提供了依据:这些发现以单细胞分辨率提供了对人类睾丸老化的细胞类型特异性机制的全面理解,并提出了潜在的治疗靶点,可用于解决与年龄相关的男性生育能力下降和性腺功能减退问题:本研究得到了国家重点研发计划(2022YFA1104100)、国家自然科学基金(32130046, 82171564, 82101669, 82371611, 82371609, 82301796)、广东省自然科学基金(2022A1515010371)和广东省医学科技重大专项(2022A1515010371)的资助、国家卫生计生委医学科技发展研究中心重大项目(HDSL202001000)、国家卫生计生委男性生殖与遗传重点实验室开放课题(KF202001)、广东省区域联合基金-青年基金项目(2021A1515110921、2022A1515111201)、中国博士后科学基金(2021M703736)。作者声明无利益冲突。
{"title":"Single-cell RNA sequencing reveals transcriptomic landscape and potential targets for human testicular ageing.","authors":"Kai Xia, Peng Luo, Jiajie Yu, Siyuan He, Lin Dong, Feng Gao, Xuren Chen, Yunlin Ye, Yong Gao, Yuanchen Ma, Cuifeng Yang, Yadong Zhang, Qiyun Yang, Dayu Han, Xin Feng, Zi Wan, Hongcai Cai, Qiong Ke, Tao Wang, Weiqiang Li, Xiang'an Tu, Xiangzhou Sun, Chunhua Deng, Andy Peng Xiang","doi":"10.1093/humrep/deae199","DOIUrl":"10.1093/humrep/deae199","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Study question: &lt;/strong&gt;What is the molecular landscape underlying the functional decline of human testicular ageing?&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Summary answer: &lt;/strong&gt;The present study provides a comprehensive single-cell transcriptomic atlas of testes from young and old humans and offers insights into the molecular mechanisms and potential targets for human testicular ageing.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;What is known already: &lt;/strong&gt;Testicular ageing is known to cause male age-related fertility decline and hypogonadism. Dysfunction of testicular cells has been considered as a key factor for testicular ageing.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Study design, size, duration: &lt;/strong&gt;Human testicular biopsies were collected from three young individuals and three old individuals to perform single-cell RNA sequencing (scRNA-seq). The key results were validated in a larger cohort containing human testicular samples from 10 young donors and 10 old donors.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Participants/materials, setting, methods: &lt;/strong&gt;scRNA-seq was used to identify gene expression signatures for human testicular cells during ageing. Ageing-associated changes of gene expression in spermatogonial stem cells (SSCs) and Leydig cells (LCs) were analysed by gene set enrichment analysis and validated by immunofluorescent and functional assays. Cell-cell communication analysis was performed using CellChat.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main results and the role of chance: &lt;/strong&gt;The single-cell transcriptomic landscape of testes from young and old men was surveyed, revealing age-related changes in germline and somatic niche cells. In-depth evaluation of the gene expression dynamics in germ cells revealed that the disruption of the base-excision repair pathway is a prominent characteristic of old SSCs, suggesting that defective DNA repair in SSCs may serve as a potential driver for increased de novo germline mutations with age. Further analysis of ageing-associated transcriptional changes demonstrated that stress-related changes and cytokine pathways accumulate in old somatic cells. Age-related impairment of redox homeostasis in old LCs was identified and pharmacological treatment with antioxidants alleviated this cellular dysfunction of LCs and promoted testosterone production. Lastly, our results revealed that decreased pleiotrophin signalling was a contributing factor for impaired spermatogenesis in testicular ageing.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Large scale data: &lt;/strong&gt;The scRNA-seq sequencing and processed data reported in this paper were deposited at the Genome Sequence Archive (https://ngdc.cncb.ac.cn/), under the accession number HRA002349.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Limitations, reasons for caution: &lt;/strong&gt;Owing to the difficulty in collecting human testis tissue, the sample size was limited. Further in-depth functional and mechanistic studies are warranted in future.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Wider implications of the findings: &lt;/strong&gt;These findings provide a comprehensive understanding of the cell type-specific mechanisms underlying human te","PeriodicalId":13003,"journal":{"name":"Human reproduction","volume":" ","pages":"2189-2209"},"PeriodicalIF":6.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11447013/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142143053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Human reproduction
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1